Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown promise in reducing the return of melanoma, the deadliest form of skin cancer. The findings were unearthed by researchers who tracked the impact of the vaccine five years after individuals participated in a Phase 2b study. A…
Politics
·
Personalized mRNA vaccine shows promise in reducing melanoma return: Research
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Chris Mason: All eyes on Downing Street - what does the PM say, and when?
Chris Mason: All eyes on Downing Street - what does the PM say, and when?20 minutes agoShareSaveAdd as preferred on Goog...
CitrixNews Staff
·
52 minutes ago
Politics
More than a third of Americans say MOU better for Iran
Administration More than a third of Americans say MOU better for Iran Comments: by Ashleigh Fields - 06/21/26 7:51 PM ET...
CitrixNews Staff
·
2 hours ago
Politics
Pence rips Trump’s Iran deal: ‘A plan to make a plan’
Administration Pence rips Trump’s Iran deal: ‘A plan to make a plan’ Comments: by Ryan Mancini - 06/21/26 6:11 PM ET Co...
CitrixNews Staff
·
4 hours ago
Politics
Pirro vows to prosecute Reflection Pool vandals
Administration Pirro vows to prosecute Reflection Pool vandals Comments: by Ashleigh Fields - 06/21/26 5:52 PM ET Comme...
CitrixNews Staff
·
4 hours ago